Manejo antibiótico actual de la peritonitis secundaria a diálisis peritoneal

Abstract

Peritonitis is one of the most frequent complications of peritoneal dialysis, which has a great impact on the quality of life, survival and nutritional status of the patient, and is characterized by the presence of cloudy-looking dialysate fluid, abdominal pain and cytological examination dialysis fluid with more than 100 leukocytes / mm3 with at least 50% polymorphonuclear cells, which could respond to chemical irritation, local necrosis, direct contusion or bacterial invasion, being the most frequent cause of PD therapeutic failure. They are classified as primary (usually monomicrobial), secondary, or tertiary, which are complicated due to multi-resistance to antibiotics. The development of peritoneal infection is produced by the arrival of bacteria to the peritoneal cavity following routes such as intraluminal, pericateter, transmural or hematogenous. There are risk factors for peritonitis that are mainly related to the connection systems and the infection of the catheter tunnel and exit site. OBJECTIVE: To know the proper management of patients diagnosed with peritonitis secondary to peritoneal dialysis through updated studies to establish a protocol to follow. METHODOLOGY: For this work, the data collection and analysis methodology will be used. CONCLUSION: Patients undergoing peritoneal dialysis have a high risk of developing peritonitis among its complications, which if detected early can be managed with antibiotics that preferably should be administered in intraperitoneal regimens to achieve greater bioavailability and better action of the medicine.